|1.||Klein, Ronald: 14 articles (05/2015 - 02/2002)|
|2.||Klein, Barbara E K: 14 articles (05/2015 - 02/2002)|
|3.||Lee, Kristine E: 6 articles (02/2014 - 11/2008)|
|4.||Wong, Tien Y: 6 articles (01/2014 - 11/2003)|
|5.||Tamborlane, William V: 6 articles (12/2006 - 01/2003)|
|6.||Shanthi, Palanivelu: 5 articles (05/2014 - 01/2012)|
|7.||Moss, Scot E: 5 articles (08/2007 - 02/2002)|
|8.||Cavalot, Franco: 4 articles (10/2015 - 01/2013)|
|9.||Sachdanandam, Panchanatham: 4 articles (05/2014 - 01/2012)|
|10.||Sundaram, Ramalingam: 4 articles (05/2014 - 01/2012)|
|1.||Body Weight (Weight, Body)
12/01/2004 - "Weight, body mass index, and glycosylated hemoglobin value also improved significantly between 3 months and 6 months. "
07/01/1999 - "Control patients had significant improvement only in glycosylated hemoglobin and body weight at 6 months. "
07/01/2007 - "In numerous studies, the coping, suitable or not, has been linked to different medical consequences of the diabetes: changes in glycosylated hemoglobin levels, in the physiological functionality, in the specific symptomatology, in body weight and body mass index. "
05/01/2007 - "Six men and 4 women were enrolled in the study (mean age, 62.4 years; mean body weight, 58.3 kg; mean body mass index, 22.22 kg/m(2); mean duration of diabetes, 9.53 years; and mean glycosylated hemoglobin concentration, 6.07%). "
10/01/2006 - "Study outcomes included feasibility measures, glycosylated hemoglobin levels (HbA1c), GI and glycemic load (GL) score of self-reported dietary intake, body weight, depression and quality of life (QOL). "
|2.||Type 2 Diabetes Mellitus (MODY)
08/01/2015 - "Predictive factors for the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors for lowering glycosylated hemoglobin (HbA1c) remain unclear in patients with type 2 diabetes mellitus. "
01/01/2012 - "The study involved 70 asymptomatic patients with type 2 diabetes mellitus (T2DM) all being treated with oral hypoglycemic medication, and having negative metabolic control levels with glycosylated hemoglobin A1c greater than 7% and less than 8%. "
06/01/2005 - "The aim of this study was to investigate the health-economic impact of maintaining glycosylated hemoglobin (HbA(1c)) values in all US patients with currently uncontrolled type 1 or type 2 diabetes mellitus at the American Diabetes Association (ADA) standard of 7.0% and the American Association of Clinical Endocrinologists (AACE) target of 6.5% compared with maintenance at current population-based values. "
07/01/1997 - "Efficacy studies have shown that moderate-intensity physical activity is associated with a one- to two-thirds lower incidence of NIDDM over 4-14 years and 15-20% lower glycosylated hemoglobin over 3-4 months among people with NIDDM. "
05/01/1993 - "A total of 47 NIDDM patients participated in the study and completed the following procedures: 1) assessment of baseline HbA1, 2) attended 3.5 days of diabetes education, 3) returned in 1 mo for a follow-up consultation with a nurse, and (4) returned in 9-12 wk for a follow-up HbA1 assessment. "
|3.||Hypoglycemia (Reactive Hypoglycemia)
01/01/2014 - "Clinical studies demonstrate an overall favorable safety profile, low risk for hypoglycemia, weight neutrality, primarily nonrenal clearance, and efficacy for glycosylated hemoglobin reduction, typically ranging from 0.6% to 0.8% depending on baseline levels. "
08/05/2015 - "Using group independent component analysis with dual-regression approach of functional magnetic resonance imaging data, we examined the functional connectivity changes of large-scale resting state networks during sequential euglycemic-hypoglycemic clamp studies in patients with type 1 diabetes and nondiabetic controls and how these changes during hypoglycemia were related to symptoms of hypoglycemia awareness and to concurrent glycosylated hemoglobin (HbA1c) levels. "
02/01/2015 - "The main measures were: compliance, persistence, metabolic control (glycosylated hemoglobin< 7%) and complications (hypoglycemia, cardiovascular events) and total costs. "
11/01/2014 - "The main measures were compliance, persistence, metabolic control (glycosylated hemoglobin level of <7%), and complications (hypoglycemia and cardiovascular events). "
08/04/2014 - "Hypoglycemic treatment should be customized (glycosylated hemoglobin levels, risk-benefit, risk of hypoglycemia, weight changes, cardiovascular risk), with a combination of drugs being necessary in most cases. "
05/01/2015 - "Ang-2 levels were significantly positively correlated with homeostasis model assessment for insulin resistance (HOMA-IR) and glycosylated hemoglobin A1c (HbA1c) (r=0.577 and 0.504, respectively, P<0.01). "
12/01/2013 - "The primary outcomes were the relative changes in glycosylated hemoglobin (HbA1c) and insulin resistance after a 30-day intervention among the four groups. "
01/01/2013 - "We investigated whether self-reported racial discrimination was associated with insulin resistance (IR) and glycosylated hemoglobin (A1c) in women with type 2 diabetes in the United States, after controlling for covariates. "
03/22/2012 - "Women with GDM had significantly higher homeostasis model assessment of insulin resistance (HOMA-IR) and glycosylated hemoglobin (HbAlc) than control women (P=0.042 and <0.01, respectively). "
05/26/2010 - "Outcomes were homeostasis model assessment of insulin resistance (HOMA IR), glycosylated hemoglobin level (HbA1C), and prevalence of pre-diabetes (6.0≤ HbA1C<6.5 and not on medication) and type 2 diabetes. "
01/01/2013 - "Glycosylated hemoglobin estimation in the setting of ACS was helpful in the diagnosis of DM to eliminate the effect of stress-induced hyperglycemia that might accompany this condition."
11/01/1989 - "The degree of sensory conduction slowing correlated well with the glycosylated hemoglobin concentrations and improved with the reduction in hyperglycemia."
01/01/2014 - "The aim of this study was to investigate the effect of hyperglycemia and glycosylated hemoglobin (GHb) in critical patients. "
12/01/1984 - "To study its specificity for hyperglycemia, stable HbA1 was determined with ion-exchange chromatography in 240 patients consecutively hospitalized in the department of internal medicine and in a non-diabetic reference population. "
10/01/2015 - "Chronic hyperglycemia was defined by plasma glycosylated hemoglobin (HbA1c) >6.5%. "
|3.||Blood Glucose (Blood Sugar)
|5.||glargine (insulin glargine)
|2.||Gastric Bypass (Roux-en-Y Gastric Bypass)
|3.||Islets of Langerhans Transplantation